|
|
|
51-200 employees
View all
|
|
biotechnology
|
|
4550 Towne Centre Ct,San Diego,California,United States
|
|
La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. GIAPREZA™ (angiotensin II), formerly known as LJPC-501, was approved by the U.S. Food and Drug Administration (FDA) on December 21, 2017 as a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. LJPC-0118 is La Jolla’s investigational product for the treatment of severe malaria. For more information, please visit www.ljpc.com.
|
La Jolla Pharmaceutical Company Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
100%
|
The widely used La Jolla Pharmaceutical Company email format is {first}.{last} (e.g. [email protected]) with 100% adoption across the company.
To contact La Jolla Pharmaceutical Company customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.